All lobbying filings

Thermo Fisher Scientific Inc.

Thermo Fisher Scientific Inc. filed a Q1 report for Thermo Fisher Scientific Inc. on April 16, 2026.

Lobbying for Thermo Fisher Scientific Inc.

As filed: THERMO FISHER SCIENTIFIC INC. for THERMO FISHER SCIENTIFIC INC.

All filings by Thermo Fisher Scientific Inc. · Everything Thermo Fisher Scientific Inc. has reported

Filing · LD-2 quarterly report Q1 report

Reporting period

1st Quarter 2026

Jan 1 - Mar 31 · Posted Apr 16, 2026

Expenses

$710,000

What this organization spent lobbying with its own staff. Reported using the LDA's own definitions (method A): the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.

Client based in

Massachusetts

Official filing document

Government bodies contacted 13

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 7

Health Issues

General discussions related to clinical trials infrastructure and government labs, and related matters. General discussions regarding diagnostic reimbursement policies. H.R. 5269/S. 2761: Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act of 2025 - all provisions of the bill. H.R. 5343/S. 1717: Ensuring Patient Access to Critical Breakthrough Products Act - all provisions of the bill.

Budget/Appropriations

H.R. 5304/S. 2587: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026 - provisions regarding FY26 NIH Funding. General discussions regarding government contract thresholds.

Homeland Security

Preparedness products and services. General discussions around government contracting opportunities.

Law Enforcement/Crime/Criminal Justice

POWER Act; all provisions of the bill.

Trade (domestic/foreign)

General discussions regarding trade and tariffs, including with respect to markets including China. United States-Mexico-Canada Agreement.

Taxation/Internal Revenue Code

General discussions regarding the expiration of key provisions of the 2017 Tax Cuts and Jobs Act, and other tax-related priorities.

Labor Issues/Antitrust/Workplace

General discussions regarding impact of U.S. federal government workforce changes on industry.

Bills named in this filing 6

H.R. 5269
RESULTS Act
S. 2761
RESULTS Act
H.R. 5343
Ensuring Patient Access to Critical Breakthrough Products Act
S. 1717
Ensuring Patient Access to Critical Breakthrough Products Act of 2025
H.R. 5304
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026
S. 2587
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.